P\S\L Group Names O'Shaughnessy MD of RxY Arm

In the UK, healthcare research specialist P\S\L Group has appointed former M3 and Cello Health exec Paul O'Shaughnessy as Managing Director of its RxY business.

The RxY division helps pharma companies track the real reasons why Rx choices are made when physicians are prescribing. O'Shaughnessy joins from M3 Global Research, where he served as EVP, Global Sales; before this he spent nearly eight years at Cello Health Insight, latterly as Global Head of Business Development and Client Services. Earlier, he was Business Development Director at healthcare specialist Branding Science, and International Business Director at GfK.

Commenting on the news, Jean-Olivier Marty, Group President of P\S\L's healthcare tracking and testing business Instar, comments: 'Since its launch, RxY has been redefining how pharmaceutical companies understand why medicines are prescribed, leveraging cutting edge technology to yield new insights. With Paul on board we are in a fantastic position to accelerate the growth of RxY'.

The group, which has regional offices in London, New York, Montreal, Kuala Lumpur, Cape Town, Querétaro (Mexico) and Luxembourg, is online at www.pslgroup.com .

All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.